Weiqing Tang Selected Research

protein phosphatase 4

1/2021	Protein Phosphatase 4 Promotes Hepatocyte Lipoapoptosis by Regulating RAC1/MLK3/JNK Pathway.
10/2018	miR‑338‑3p mediates gluconeogenesis via targeting of PP4R1 in hepatocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiqing Tang Research Topics

Disease

4	Insulin Resistance 12/2021 - 11/2010
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2007
3	Cardiotoxicity 01/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
2	Fatty Liver 01/2022 - 11/2010
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 12/2010
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 05/2009
2	Necrosis 10/2018 - 07/2018
1	Carcinogenesis 01/2022
1	Sepsis (Septicemia) 11/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Heart Failure 01/2020
1	Facial Paralysis (Facial Palsy) 01/2020
1	Dysbiosis 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Hypertrophy 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Brain Neoplasms (Brain Tumor) 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Neoplasms (Cancer) 07/2018
1	Adenocarcinoma 07/2018
1	Insulinoma 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Hemangioma (Angioma) 01/2017
1	Glucose Intolerance 01/2017
1	Obesity 12/2010
1	Hyperinsulinism (Hyperinsulinemia) 11/2010
1	Hypercholesterolemia 11/2010
1	Atherosclerosis 04/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2009
1	Sitosterolemia 02/2009

Drug/Important Bio-Agent (IBA)

5	CholesterolIBA 01/2022 - 07/2007
3	LipidsIBA 01/2022 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
3	Insulin (Novolin)FDA Link 12/2021 - 11/2010
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2019
2	protein phosphatase 4IBA 01/2021 - 10/2018
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2020 - 01/2020
1	Oleic Acid (Oleate)IBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	norbinaltorphimineIBA 11/2021
1	Opioid Receptors (Opioid Receptor)IBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	LipopolysaccharidesIBA 11/2021
1	Butorphanol (BC 2627)FDA LinkGeneric 11/2021
1	CaspasesIBA 01/2021
1	AdiponectinIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	necrostatin-1IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 01/2021
1	naringinIBA 01/2020
1	Perilipin-1IBA 01/2020
1	Type 1 Angiotensin ReceptorIBA 01/2019
1	Telmisartan (Micardis)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 10/2018
1	Tyrosine Kinase InhibitorsIBA 10/2018
1	Iodine-125IBA 07/2018
1	LDL Receptors (LDL Receptor)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 12/2010
1	Ezetimibe (Zetia)FDA Link 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	DiosgeninIBA 05/2009
1	thermozymocidin (myriocin)IBA 04/2009
1	SphingomyelinsIBA 04/2009
1	Apolipoproteins E (ApoE)IBA 04/2009
1	Phytosterols (Plant Sterols)IBA 02/2009

Therapy/Procedure

1	Sclerotherapy 01/2020
1	Radiotherapy 10/2018
1	Aftercare (After-Treatment) 07/2018
1	Brachytherapy 07/2018
1	Therapeutics 07/2018
1	Oral Administration 04/2009